Mike Kratky
Stock Analyst at Leerink Partners
(3.24)
# 1,025
Out of 5,182 analysts
40
Total ratings
40.91%
Success rate
22.38%
Average return
Main Sectors:
Stocks Rated by Mike Kratky
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| ZBH Zimmer Biomet Holdings | Initiates: Market Perform | $101 | $95.34 | +5.94% | 1 | Apr 13, 2026 | |
| SYK Stryker | Initiates: Outperform | $410 | $347.24 | +18.07% | 1 | Apr 13, 2026 | |
| PRCT PROCEPT BioRobotics | Maintains: Outperform | $55 → $30 | $23.46 | +27.88% | 2 | Feb 26, 2026 | |
| PODD Insulet | Maintains: Outperform | $386 → $360 | $197.81 | +81.99% | 2 | Feb 19, 2026 | |
| TXG 10x Genomics | Maintains: Market Perform | $22 → $20 | $23.58 | -15.18% | 5 | Jan 27, 2026 | |
| PEN Penumbra | Downgrades: Market Perform | $374 | $331.48 | +12.83% | 2 | Jan 16, 2026 | |
| BSX Boston Scientific | Maintains: Outperform | $127 → $128 | $63.18 | +102.60% | 2 | Oct 1, 2025 | |
| INSP Inspire Medical Systems | Maintains: Market Perform | $116 → $97 | $54.92 | +76.62% | 7 | Aug 15, 2025 | |
| MDT Medtronic | Initiates: Outperform | $110 | $88.00 | +25.00% | 1 | Jun 16, 2025 | |
| BBNX Beta Bionics | Initiates: Outperform | $28 | $10.63 | +163.41% | 1 | Feb 24, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $90 → $87 | $63.12 | +37.83% | 2 | Oct 25, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Outperform | $34 → $45 | $20.10 | +123.88% | 2 | Apr 25, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | $22 | $14.88 | +47.85% | 1 | Jan 30, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | $42 | $34.44 | +21.95% | 1 | Oct 16, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | $342 | $458.96 | -25.48% | 1 | Oct 16, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Market Perform | $75 | $78.12 | -3.99% | 1 | Oct 16, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | $9 | $33.47 | -73.11% | 1 | Oct 16, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $33 → $45 | $1.30 | +3,361.54% | 2 | Jan 24, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $145 → $315 | $525.67 | -40.08% | 1 | Dec 20, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Market Perform | $26 → $31 | $88.53 | -64.98% | 2 | Dec 15, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $12 → $14 | $25.12 | -44.27% | 1 | Nov 4, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $32 → $40 | $14.80 | +170.27% | 1 | Aug 15, 2022 |
Zimmer Biomet Holdings
Apr 13, 2026
Initiates: Market Perform
Price Target: $101
Current: $95.34
Upside: +5.94%
Stryker
Apr 13, 2026
Initiates: Outperform
Price Target: $410
Current: $347.24
Upside: +18.07%
PROCEPT BioRobotics
Feb 26, 2026
Maintains: Outperform
Price Target: $55 → $30
Current: $23.46
Upside: +27.88%
Insulet
Feb 19, 2026
Maintains: Outperform
Price Target: $386 → $360
Current: $197.81
Upside: +81.99%
10x Genomics
Jan 27, 2026
Maintains: Market Perform
Price Target: $22 → $20
Current: $23.58
Upside: -15.18%
Penumbra
Jan 16, 2026
Downgrades: Market Perform
Price Target: $374
Current: $331.48
Upside: +12.83%
Boston Scientific
Oct 1, 2025
Maintains: Outperform
Price Target: $127 → $128
Current: $63.18
Upside: +102.60%
Inspire Medical Systems
Aug 15, 2025
Maintains: Market Perform
Price Target: $116 → $97
Current: $54.92
Upside: +76.62%
Medtronic
Jun 16, 2025
Initiates: Outperform
Price Target: $110
Current: $88.00
Upside: +25.00%
Beta Bionics
Feb 24, 2025
Initiates: Outperform
Price Target: $28
Current: $10.63
Upside: +163.41%
Oct 25, 2024
Maintains: Outperform
Price Target: $90 → $87
Current: $63.12
Upside: +37.83%
Apr 25, 2024
Upgrades: Outperform
Price Target: $34 → $45
Current: $20.10
Upside: +123.88%
Jan 30, 2024
Initiates: Outperform
Price Target: $22
Current: $14.88
Upside: +47.85%
Oct 16, 2023
Initiates: Outperform
Price Target: $42
Current: $34.44
Upside: +21.95%
Oct 16, 2023
Initiates: Outperform
Price Target: $342
Current: $458.96
Upside: -25.48%
Oct 16, 2023
Initiates: Market Perform
Price Target: $75
Current: $78.12
Upside: -3.99%
Oct 16, 2023
Initiates: Outperform
Price Target: $9
Current: $33.47
Upside: -73.11%
Jan 24, 2023
Maintains: Outperform
Price Target: $33 → $45
Current: $1.30
Upside: +3,361.54%
Dec 20, 2022
Maintains: Outperform
Price Target: $145 → $315
Current: $525.67
Upside: -40.08%
Dec 15, 2022
Maintains: Market Perform
Price Target: $26 → $31
Current: $88.53
Upside: -64.98%
Nov 4, 2022
Maintains: Outperform
Price Target: $12 → $14
Current: $25.12
Upside: -44.27%
Aug 15, 2022
Maintains: Outperform
Price Target: $32 → $40
Current: $14.80
Upside: +170.27%